PIM1 and glioblastoma: In order to identify protein targets that may be responsible for the sensitization of GBM cells to TRAIL following PIM kinases inhibition, we performed omics assays by mass spectrometry (MS-MS) to analyze the global phosphoproteomic signature after PIM knockdown.